Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:28 PM
Ignite Modification Date:
2025-12-24 @ 3:28 PM
NCT ID:
NCT02575092
Eligibility Criteria:
Inclusion Criteria:
From November 2015 to April 2017 , all consecutive patients admitted to the participating centers for the patients who undergoing coronary artery diagnosis and treatment(CAG or PCI) will been considered eligibleļ¼about 5500 cases.
Exclusion Criteria:
* Who requires long-term peritoneal or hemodialysis.
* Who had been underwent a kidney transplantation.
* Renal failure with a creatinine level \>3 mg/dl.
* Who had been received the contrast agent within 2 weeks or had been received metformin, aminoglycoside antibiotics or acetylcysteine within 48 hours.
* Iodine allergy, acute and chronic infections and hyperthyroidism.
* Left ventricular ejection fraction \<30%.
* Secondary hypertension.
* Who can not be tolerated ACEI.
* Any other surgical contraindications.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
85 Years
Study:
NCT02575092
Study Brief:
Protocol Section:
NCT02575092